Attention deficit hyperactivity disorder (ADHD) is a听condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
The global Children Attention Deficit and Hyperactivity Disorder market is projected to reach US$ 12980 million in 2029, increasing from US$ 8085 million in 2022, with the CAGR of 7.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Children Attention Deficit and Hyperactivity Disorder 91制片厂.
The Attention Deficit and Hyperactivity Disorder (ADHD) market is driven by the rising awareness of the disorder and its diagnosis, coupled with the increasing prevalence of ADHD among children and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily life, educational performance, and workplace productivity contributes to market growth as individuals and healthcare providers seek effective treatment options. Moreover, advancements in diagnostic methods, therapy approaches, and medication options align with improved management of ADHD symptoms. However, the market also faces challenges, including accurate diagnosis and tailoring treatment plans to individual patient needs. Additionally, addressing concerns about overdiagnosis and appropriate medication usage can pose obstacles for healthcare professionals. To succeed, stakeholders must focus on providing comprehensive assessment and tailored interventions, fostering public awareness, and addressing the challenges to meet the increasing demand for accurate diagnosis and effective management of ADHD.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Children Attention Deficit and Hyperactivity Disorder market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Segment by Type
Stimulant
Non-stimulant
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Children Attention Deficit and Hyperactivity Disorder report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Children Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Application
1.3.1 Global Children Attention Deficit and Hyperactivity Disorder Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Children Attention Deficit and Hyperactivity Disorder Market Perspective (2018-2029)
2.2 Children Attention Deficit and Hyperactivity Disorder Growth Trends by Region
2.2.1 Global Children Attention Deficit and Hyperactivity Disorder Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Children Attention Deficit and Hyperactivity Disorder Historic Market Size by Region (2018-2023)
2.2.3 Children Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2024-2029)
2.3 Children Attention Deficit and Hyperactivity Disorder Market Dynamics
2.3.1 Children Attention Deficit and Hyperactivity Disorder Industry Trends
2.3.2 Children Attention Deficit and Hyperactivity Disorder Market Drivers
2.3.3 Children Attention Deficit and Hyperactivity Disorder Market Challenges
2.3.4 Children Attention Deficit and Hyperactivity Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Children Attention Deficit and Hyperactivity Disorder Players by Revenue
3.1.1 Global Top Children Attention Deficit and Hyperactivity Disorder Players by Revenue (2018-2023)
3.1.2 Global Children Attention Deficit and Hyperactivity Disorder Revenue Market Share by Players (2018-2023)
3.2 Global Children Attention Deficit and Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Children Attention Deficit and Hyperactivity Disorder Revenue
3.4 Global Children Attention Deficit and Hyperactivity Disorder Market Concentration Ratio
3.4.1 Global Children Attention Deficit and Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Children Attention Deficit and Hyperactivity Disorder Revenue in 2022
3.5 Children Attention Deficit and Hyperactivity Disorder Key Players Head office and Area Served
3.6 Key Players Children Attention Deficit and Hyperactivity Disorder Product Solution and Service
3.7 Date of Enter into Children Attention Deficit and Hyperactivity Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Children Attention Deficit and Hyperactivity Disorder Breakdown Data by Type
4.1 Global Children Attention Deficit and Hyperactivity Disorder Historic Market Size by Type (2018-2023)
4.2 Global Children Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2024-2029)
5 Children Attention Deficit and Hyperactivity Disorder Breakdown Data by Application
5.1 Global Children Attention Deficit and Hyperactivity Disorder Historic Market Size by Application (2018-2023)
5.2 Global Children Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Children Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
6.2 North America Children Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Children Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023)
6.4 North America Children Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Children Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
7.2 Europe Children Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Children Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023)
7.4 Europe Children Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Children Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
8.2 Asia-Pacific Children Attention Deficit and Hyperactivity Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Children Attention Deficit and Hyperactivity Disorder Market Size by Region (2018-2023)
8.4 Asia-Pacific Children Attention Deficit and Hyperactivity Disorder Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Children Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
9.2 Latin America Children Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Children Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023)
9.4 Latin America Children Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Children Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
10.2 Middle East & Africa Children Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Children Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2023)
10.4 Middle East & Africa Children Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Children Attention Deficit and Hyperactivity Disorder Introduction
11.1.4 Takeda Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Children Attention Deficit and Hyperactivity Disorder Introduction
11.2.4 Johnson & Johnson Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Children Attention Deficit and Hyperactivity Disorder Introduction
11.3.4 Novartis Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Children Attention Deficit and Hyperactivity Disorder Introduction
11.4.4 Eli Lilly Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Tris Pharma
11.5.1 Tris Pharma Company Detail
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Children Attention Deficit and Hyperactivity Disorder Introduction
11.5.4 Tris Pharma Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.5.5 Tris Pharma Recent Development
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Detail
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Children Attention Deficit and Hyperactivity Disorder Introduction
11.6.4 Neos Therapeutics Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.6.5 Neos Therapeutics Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Detail
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Children Attention Deficit and Hyperactivity Disorder Introduction
11.7.4 Mallinckrodt Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.7.5 Mallinckrodt Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Detail
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Children Attention Deficit and Hyperactivity Disorder Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Detail
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Children Attention Deficit and Hyperactivity Disorder Introduction
11.9.4 Noven Pharmaceuticals Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.9.5 Noven Pharmaceuticals Recent Development
11.10 Purdue Parma
11.10.1 Purdue Parma Company Detail
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Children Attention Deficit and Hyperactivity Disorder Introduction
11.10.4 Purdue Parma Revenue in Children Attention Deficit and Hyperactivity Disorder Business (2018-2023)
11.10.5 Purdue Parma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
听
听
*If Applicable.